IL60839A - Divisible tablet having controlled and delayed release of a pharmaceutically active substance - Google Patents

Divisible tablet having controlled and delayed release of a pharmaceutically active substance

Info

Publication number
IL60839A
IL60839A IL60839A IL6083980A IL60839A IL 60839 A IL60839 A IL 60839A IL 60839 A IL60839 A IL 60839A IL 6083980 A IL6083980 A IL 6083980A IL 60839 A IL60839 A IL 60839A
Authority
IL
Israel
Prior art keywords
controlled
active substance
pharmaceutically active
delayed release
divisible tablet
Prior art date
Application number
IL60839A
Other languages
English (en)
Other versions
IL60839A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH7514/79A external-priority patent/CH648754A5/de
Priority claimed from CH395980A external-priority patent/CH646330A5/de
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL60839A0 publication Critical patent/IL60839A0/xx
Publication of IL60839A publication Critical patent/IL60839A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL60839A 1979-08-16 1980-08-14 Divisible tablet having controlled and delayed release of a pharmaceutically active substance IL60839A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH7514/79A CH648754A5 (en) 1979-08-16 1979-08-16 Pharmaceutical slow release tablet
CH395980A CH646330A5 (en) 1980-05-21 1980-05-21 Divisible slow-release pharmaceutical tablets

Publications (2)

Publication Number Publication Date
IL60839A0 IL60839A0 (en) 1980-10-26
IL60839A true IL60839A (en) 1983-11-30

Family

ID=25694276

Family Applications (1)

Application Number Title Priority Date Filing Date
IL60839A IL60839A (en) 1979-08-16 1980-08-14 Divisible tablet having controlled and delayed release of a pharmaceutically active substance

Country Status (20)

Country Link
US (1) US4353887A (da)
AU (1) AU531058B2 (da)
CA (1) CA1158555A (da)
DE (1) DE3030622C2 (da)
DK (1) DK153772C (da)
ES (1) ES494274A0 (da)
FI (1) FI76691C (da)
FR (1) FR2462908A1 (da)
GB (1) GB2057878B (da)
GR (1) GR69943B (da)
IE (1) IE50108B1 (da)
IL (1) IL60839A (da)
IT (1) IT1145285B (da)
LU (1) LU82718A1 (da)
MY (1) MY8700198A (da)
NL (1) NL8004616A (da)
NO (1) NO156274C (da)
NZ (1) NZ194681A (da)
PT (1) PT71706B (da)
SE (1) SE445802B (da)

Families Citing this family (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN158328B (da) * 1981-03-09 1986-10-18 Ici Plc
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
JPS58152813A (ja) * 1982-03-08 1983-09-10 Sumitomo Chem Co Ltd 鮮明な刻印を有する錠剤およびその製法
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
US4591500A (en) * 1983-04-25 1986-05-27 Microencapsulation S.A. Tablet having the shape of a capsule, process and device for its preparation
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
US4631305A (en) * 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
ES2041336T3 (es) * 1987-11-20 1993-11-16 Greither, Peter Capsula y procedimiento para su fabricacion.
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
KR900700071A (ko) * 1987-12-17 1990-08-11 로버어트 에이 아미테이지 트리-스코어(Tri-scored) 약 정제
USD315223S (en) 1989-05-03 1991-03-05 Warner-Lambert Company Tablet
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
ATE114472T1 (de) * 1989-09-21 1994-12-15 American Cyanamid Co System des typs ''einmal täglich'' zur gepulsten minocyclinabgabe.
US5009896A (en) * 1989-10-04 1991-04-23 Akzo N.V. Multi-fractionable tablet structure
US5213738A (en) * 1990-05-15 1993-05-25 L. Perrigo Company Method for making a capsule-shaped tablet
US5061494A (en) * 1990-06-14 1991-10-29 The Upjohn Comany Tri-scored drug tablet
DE4100920A1 (de) * 1991-01-15 1992-07-16 Degussa Wirkstoffzubereitung zur oralen verabreichung an wiederkaeuer
GB9101502D0 (en) * 1991-01-23 1991-03-06 Controlled Therapeutics Sct Controlled release compositions
US5262173A (en) * 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline
USD361837S (en) 1993-06-28 1995-08-29 Solvay-Duphar B.V. Breakable tablet
US5398850A (en) * 1993-08-06 1995-03-21 River Medical, Inc. Gas delivery apparatus for infusion
US5571261A (en) * 1993-08-06 1996-11-05 River Medical, Inc Liquid delivery device
US5398851A (en) * 1993-08-06 1995-03-21 River Medical, Inc. Liquid delivery device
FR2709420B1 (fr) * 1993-09-01 1995-11-17 Sogeval Comprimé vétérinaire plus spécialement destiné aux chats.
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6129930A (en) * 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US5700245A (en) * 1995-07-13 1997-12-23 Winfield Medical Apparatus for the generation of gas pressure for controlled fluid delivery
US5756124A (en) * 1995-08-07 1998-05-26 Invamed, Inc. Multi-scored pharmaceutical tablets
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
GB9624563D0 (en) * 1996-11-27 1997-01-15 Smithkline Beecham Plc Product
IN190906B (da) * 1998-04-03 2003-08-30 Kyowa Hakko Kogyo Company Ltd
US6602521B1 (en) * 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
DE19856147A1 (de) 1998-12-04 2000-06-08 Knoll Ag Teilbare feste Dosierungsformen und Verfahren zu ihrer Herstellung
GB9914620D0 (en) * 1999-06-23 1999-08-25 Eu Pharma Ltd Divisible tablets
WO2001000176A1 (en) * 1999-06-23 2001-01-04 Eu Pharma Ltd. Divisible tablets
USD440650S1 (en) 2000-01-27 2001-04-17 Watson Pharmaceuticals, Inc. Tablet
SE0100200D0 (sv) * 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
TW200502000A (en) * 2003-03-28 2005-01-16 Kyowa Hakko Kogyo Kk Dividing tablet
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE602004023861D1 (de) 2003-09-03 2009-12-10 Novartis Ag Verwendung von oxcarbazepin zur verbesserung des schlafes bei patienten die an chronischem schmerz leiden
FR2859632B1 (fr) * 2003-09-15 2005-11-18 Arrow Generiques Comprime multisecable a observance amelioree.
DE202004002700U1 (de) * 2004-02-20 2004-04-29 Desitin Arzneimittel Gmbh Viertelbare Tablette
CA2565029C (en) * 2004-05-21 2013-09-03 Lawrence Solomon Immediate release pharmaceutical tablets with height greater than width
CN1964703B (zh) * 2004-05-21 2012-07-04 阿库-伯雷克技术公司 高度超过宽度的速释药片
US7838031B2 (en) * 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
GB0423964D0 (en) * 2004-10-28 2004-12-01 Jagotec Ag Dosage form
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
EP1712224A1 (en) * 2005-04-12 2006-10-18 Alexander von Mérey Divisible rectangular flat tablet
RU2008113439A (ru) 2005-09-09 2009-10-20 Лабофарм Инк. (CA) Композиции с замедленным высвобождением лекарственного средства
TWI274889B (en) * 2005-10-06 2007-03-01 Elan Microelectronics Corp Resistive touch screen measurement system
US20070160960A1 (en) * 2005-10-21 2007-07-12 Laser Shot, Inc. System and method for calculating a projectile impact coordinates
US7985419B1 (en) 2006-12-22 2011-07-26 Watson Laboratories, Inc. Divisible tablet and associated methods
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
WO2008140461A1 (en) * 2007-05-16 2008-11-20 Fmc Corporation Solid form
WO2008140459A1 (en) * 2007-05-16 2008-11-20 Fmc Corporation Solid form
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
US20080286344A1 (en) * 2007-05-16 2008-11-20 Olivia Darmuzey Solid form
US20080286343A1 (en) * 2007-05-16 2008-11-20 Dzenana Cengic Solid form
WO2008140460A1 (en) * 2007-05-16 2008-11-20 Fmc Corporation Solid form
CA2713128C (en) 2008-01-25 2016-04-05 Gruenenthal Gmbh Pharmaceutical dosage form
FR2928836B1 (fr) * 2008-03-21 2011-08-26 Servier Lab Forme galenique secable permettant une liberation modifiee du principe actif
BRPI0912014A2 (pt) 2008-05-09 2019-03-06 Grünenthal GmbH processo para a preparação de uma formulação em pó intermediária e uma forma de dosagem sólida final sob uso de uma etapa de congelamento por atomização
USD589606S1 (en) 2008-06-03 2009-03-31 Solvay Pharmaceuticals B.V. Pharmaceutical tablet
TW201006473A (en) * 2008-08-13 2010-02-16 Orient Pharma Co Ltd Bi-layer medicine tablet containing Zaleplon
US20100104687A1 (en) * 2008-10-24 2010-04-29 Kaplan Allan S Segmented confectionery products
CN102573805A (zh) 2009-07-22 2012-07-11 格吕伦塔尔有限公司 热熔挤出的控制释放剂型
RU2015138422A (ru) 2009-07-22 2018-12-25 Грюненталь Гмбх Стабильная при окислении, прочная на излом лекарственная форма
US9579285B2 (en) 2010-02-03 2017-02-28 Gruenenthal Gmbh Preparation of a powdery pharmaceutical composition by means of an extruder
NZ607392A (en) 2010-09-02 2015-03-27 Gruenenthal Chemie Tamper resistant dosage form comprising inorganic salt
BR112013005234A2 (pt) 2010-09-02 2016-05-03 Gruenenthal Gmbh forma de dosagem resistente à violação compreendendo um polímero aniônico.
JO3283B1 (ar) 2011-04-26 2018-09-16 Sanofi Sa تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI)
PE20141638A1 (es) 2011-07-29 2014-11-22 Gruenenthal Chemie Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
RS56527B1 (sr) 2011-07-29 2018-02-28 Gruenenthal Gmbh Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu
MX356421B (es) 2012-02-28 2018-05-29 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
DK2838512T3 (da) 2012-04-18 2018-11-19 Gruenenthal Gmbh Manipulationssikret og dosisdumpingsikret farmaceutisk doseringsform
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
WO2014043553A1 (en) * 2012-09-15 2014-03-20 Slaboden Jeffery K Dissolvable tablet
AR096439A1 (es) 2013-05-29 2015-12-30 Gruenenthal Gmbh Forma de dosificación resistente al uso indebido que contiene una o más partículas
JP6445537B2 (ja) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 1個または複数の粒子を含有する改変防止(tamper−resistant)剤形
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
AU2014356581C1 (en) 2013-11-26 2020-05-28 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
USD723155S1 (en) 2014-02-11 2015-02-24 Pharmavite Llc Tablet
MX2016014738A (es) 2014-05-12 2017-03-06 Gruenenthal Gmbh Formulacion en capsula de liberacion inmediata resistente a alteraciones que comprende tapentadol.
MX2016015417A (es) 2014-05-26 2017-02-22 Gruenenthal Gmbh Multiparticulas protegidas contra vertido de dosis etanolico.
WO2016008975A1 (en) 2014-07-18 2016-01-21 Sanofi Method for predicting the outcome of a treatment with aflibercept of a patient suspected to suffer from a cancer
JP2018517676A (ja) 2015-04-24 2018-07-05 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 即時放出および溶媒抽出に対する耐性を有する改変防止製剤
AU2016319203A1 (en) 2015-09-10 2018-02-22 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
USD805726S1 (en) * 2016-03-11 2017-12-26 Mars, Incorporated Pet food
US20200060218A1 (en) 2018-08-22 2020-02-27 Land O'lakes, Inc. Extruded, multi-portioned butter products and system and methods of producing same
USD869116S1 (en) 2018-08-22 2019-12-10 Land O'lakes, Inc. Butter stick
USD909148S1 (en) 2018-08-22 2021-02-02 Land O'lakes, Inc. Die
USD869117S1 (en) 2018-08-22 2019-12-10 Land O'lakes, Inc. Butter stick
USD909825S1 (en) 2018-08-22 2021-02-09 Land O'lakes, Inc. Die
USD871016S1 (en) 2019-05-10 2019-12-31 Land O'lakes, Inc. Butter stick
USD918526S1 (en) 2019-11-12 2021-05-11 Land O'lakes, Inc. Butter stick
MX2022011505A (es) 2020-03-16 2022-10-07 Gruenenthal Gmbh Comprimido ranurado.
US20210378968A1 (en) * 2020-05-28 2021-12-09 Johnson & Johnson Consumer Inc. Multi-cavity customizable dosage forms

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE104533C1 (da) *
GB189400A (en) * 1922-05-02 1922-11-30 Fred William Walton Improvements in the manufacture of chocolate cakes
GB238264A (en) * 1924-04-09 1925-08-10 Henry Charles Clark Improvements relating to table jellies
US1836604A (en) * 1929-06-01 1931-12-15 Simon M Meyer Sugar unit
US2052376A (en) * 1933-05-18 1936-08-25 Edgar G Zellers Insoluble pill or tablet for internal medicinal uses
USD91644S (en) 1933-12-22 1934-03-06 Alex Blackstone Design for a proprietary medicine bar
US2132690A (en) * 1937-06-03 1938-10-11 Perley A Hilliard Edible material in ribbon form
US2410110A (en) * 1943-01-14 1946-10-29 Brewer & Company Inc Method of making tablets
US2410417A (en) * 1944-03-04 1946-11-05 Lever Brothers Ltd Vitamin and mineral dietary supplement and method of making
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
US2996431A (en) * 1953-12-16 1961-08-15 Barry Richard Henry Friable tablet and process for manufacturing same
US2811483A (en) * 1954-12-09 1957-10-29 Pfizer & Co C Pharmaceutical composition and process for preparing the same
US2853420A (en) * 1956-01-25 1958-09-23 Lowey Hans Ethyl cellulose coatings for shaped medicinal preparations
GB1022171A (en) * 1961-06-15 1966-03-09 Wellcome Found Prolonged release oral pharmaceutical tablets and their manufacture
US3166476A (en) * 1961-09-01 1965-01-19 Lowey Hans Powder based tablets
GB993291A (en) * 1961-12-06 1965-05-26 Thomas Lee Cooper Tablets, pills, pellets and the like
US3115441A (en) * 1962-06-06 1963-12-24 Victor M Hermelin Timed release pharmaceutical preparations and method of making the same
US3336200A (en) * 1963-05-28 1967-08-15 Warner Lambert Pharmaceutical Tablet structure
BE632692A (da) * 1963-05-28
FI44458B (da) * 1963-06-18 1971-08-02 Ucb Sa
USD202467S (en) 1963-10-07 1965-10-05 Jacques Guilmot Pharmaceutical tablets
USD201497S (en) 1964-09-28 1965-06-29 Warner Lambert Co Tablet
FR1603314A (en) * 1965-02-23 1971-04-05 Pharmaceutical tablets - having a core and a matrix material
CH502891A (de) * 1967-11-21 1971-02-15 Ciba Geigy Ag Technische, gekerbte Tablette
GB1368574A (en) * 1971-02-12 1974-10-02 Ives Lab Inc Divisible tablet
GB1387643A (en) * 1971-03-16 1975-03-19 Ives Lab Inc Divisible tablet
US3883647A (en) * 1972-12-06 1975-05-13 Ives Lab Tablet formulation
US4215104A (en) * 1979-03-26 1980-07-29 Mead Johnson & Company Multi-fractionable tablet structure
US4258027A (en) * 1979-03-26 1981-03-24 Mead Johnson & Company Multi-fractionable tablet structure

Also Published As

Publication number Publication date
MY8700198A (en) 1987-12-31
AU531058B2 (en) 1983-08-11
NO802447L (no) 1981-02-17
SE445802B (sv) 1986-07-21
DK153772C (da) 1989-01-23
PT71706A (en) 1980-09-01
PT71706B (en) 1981-06-17
DK153772B (da) 1988-09-05
IT1145285B (it) 1986-11-05
FI76691B (fi) 1988-08-31
AU6148180A (en) 1981-02-19
FI76691C (fi) 1988-12-12
GB2057878A (en) 1981-04-08
FR2462908A1 (fr) 1981-02-20
FI802542A7 (fi) 1981-02-17
DE3030622C2 (de) 1996-05-30
GR69943B (da) 1982-07-21
ES8106231A1 (es) 1981-08-01
IT8049501A0 (it) 1980-08-14
GB2057878B (en) 1983-07-20
US4353887A (en) 1982-10-12
NL8004616A (nl) 1981-02-18
LU82718A1 (de) 1981-03-24
IE801727L (en) 1981-02-16
DK354580A (da) 1981-02-17
NZ194681A (en) 1983-06-17
NO156274C (no) 1987-08-26
CA1158555A (en) 1983-12-13
NO156274B (no) 1987-05-18
FR2462908B1 (da) 1983-07-08
SE8005759L (sv) 1981-02-17
IL60839A0 (en) 1980-10-26
ES494274A0 (es) 1981-08-01
IE50108B1 (en) 1986-02-19
DE3030622A1 (de) 1981-03-26

Similar Documents

Publication Publication Date Title
IL60839A0 (en) Divisible tablet having controlled and delayed release of a pharmaceutically active substance
ZA805015B (en) Divisible tablet having controlled and delayed release of the active substance
EP0018605A3 (en) Enterosoluble capsule and methods for its preparation
JPS5646822A (en) Medicine controlling active component release
PT70719A (en) Process for the preparation of tablets with retarded liberation of the active agent in which tablets the rate of liberation of the active agent is predetermined
HU179474B (en) Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
GB2046209B (en) Encapsulation of chemically active biologically active materials and viable tissue
PH17548A (en) Pharmacologically active substituted-3-amino-sydnone-imines and process for their preparation
DE2856901D2 (de) Form of implant medicament and preparation process
JPS5618982A (en) Pyrimidine derivatives and medicinal drug containing them
JPS5594255A (en) Preparation of tablet and its pilling machine
IL81232A0 (en) Pharmaceutical composition with sustained release of the active component and a process for the preparation thereof
JPS5697257A (en) Pharmaceutically active peptides
PT71066A (en) Process for the preparation of a pharmaceutical composition having analgesic and myotonolytical activity
ZA78550B (en) Preparation of insecticides and acaricides
IL59764A0 (en) Drug on the basis of dihydroergo-toxine and procedure for its manufacture
IL61764A0 (en) Solutions of bormoxynil and ioxynil esters
JPS56131509A (en) Agricultural drug and manufacture
JPS55100314A (en) Continuously releasing drug composition
CS183843B2 (en) Insecticide and acaricide agent and mode of production of active substances
ZW18980A1 (en) Depot preparation with prolonged release of active substance
GB2016012B (en) Pharmaceutically active decahydro-isoquinoline derivatives
GB2030140B (en) Pharmaceutically active indane derivatives
GB2001634B (en) Pharmaceutically active compound methods for the preparation and use thereof
JPS55147247A (en) Therapeutically active salicylamide esters* their manufacture and related pharmaceutical composition

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed